Consider Pros and Cons of Zepbound or Wegovy for Obesity
January 2024
You’ll hear debate about the role of injectable tirzepatide (Zepbound) or semaglutide (Wegovy) for obesity.
Tirzepatide is the same ingredient in Mounjaro for type 2 diabetes. It’s a dual agonist...at glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
Semaglutide is the same GLP-1 agonist in injectable Ozempic or oral Rybelsus for type 2 diabetes.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote